Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT04165941 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04165941
- Sponsor
- University of Alabama at Birmingham
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-11
- Primary completion
- 2026-12-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.